Abstract
Steroid 21-hydroxylase deficiency (21OHD) compromises about 95% of all cases of congenital adrenal hyperplasia. We have characterized the disease-causing mutations in the steroid 21-hydroxylase genes of 19 Chilean patients (12 females and 7 males) with the simple virilizing (SV) form of 21OHD and compared them with other SV-populations. Using allele-specific polymerase chain reaction, we identified lesions in 28 chromosomes out of 38 tested (73.7%). The most frequent finding was the mutation I173N= 12/38 (31.6%) similar as described in Caucasian, Asian and other Hispanic populations, where this mutation represents around 20–40% of the genetic defects in the CYP21B gene. The mutation V282L=4/38 (10.5%) and deletion (Del) or large gene conversion (LGC)=3/38 (7.9%) were also frequently detected. Only 2 alleles carried the mutation I2 splice (5.3%), this frequency is lower than that reported in Caucasian or in Mexican populations. We did not find alleles with the mutations R357W, Cluster E6, P31L and P454S in these patients. The complete genotype was determined in 11/19 patients (58%) and one allele in 6/19 patients (31.6%). In summary, about 30% of the Chilean population with SV 21OHD presented the missense mutation I173N as described in other populations. The frequency of the other lesions showed differences even between populations with similar genetic background.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
New M.I., White P.C., Pang S., Dupont B., Speiser P.W. The adrenal hyperplasias. In: Scriver C.R., Beaudet A.L., Sly W.S., Valle D. (Eds.), The metabolic basis of inherited disease. McGraw-Hill, New York, 1989, vol. 2, pp. 1881–1917.
Pang S., Clark A. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: newborn screening and its relationship to the diagnosis and treatment of the disorder. Screening 1993, 2: 105–139.
Miller W.L. Genetics, diagnosis and management of 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 1994, 78: 241–246.
Higashi Y., Yoshioka H., Yamane M., Gotoh O., Fujii-Kuriyama Y. Complete sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: A pseudogene and a genuine gene. Proc. Natl. Acad. Sci. USA 1986, 83: 2841–2845.
White P.C., New M.I., Dupont B. Structure of the human steroid 21-hydroxylase genes. Proc. Natl. Acad. Sci. USA 1986, 83: 5111–5115.
Wedell A. Molecular genetics of congenital adrenal hyperplasia (21-hydroxylase deficiency): implications for diagnosis, prognosis and treatment. Acta Paediatr. 1998, 87: 159–164.
Morel Y., Miller W.L. Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Adv. Hum. Genet. 1991, 133: 368–375.
Fardella C.E., Miller W.L. Molecular biology of mineralocorticoid metabolism. Annu. Rev. Nutr. 1996, 16: 443–470.
New M.I. Diagnosis and management of congenital adrenal hyperplasia. Annu. Rev. Med. 1998, 49: 311–328.
Weddel A. Molecular approaches for the diagnosis of 21-hydroxylase deficiency and congenital adrenal hyperplasia. DNA technology. Clin. Lab. Med. 1996, 16: 125–137.
Fardella C., Poggi H., Pineda P., Soto J., Torrealba I., Cattani A., Oestreicher E., Foradori A. Salt-wasting congenital adrenal hyperplasia: Detection of mutations in CYP21B gene in a Chilean population. J. Clin. Endocrinol. Metab. 1998, 83: 3357–3360.
David M., Forest M.G. Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency. J. Pediatr. 1984, 105: 779–803.
Speiser P.W., Laforgia N., Kato K., Pareira J., Khan R., Yang S.Y., Whorwood C., White P.C., Elias S., Schriock ??, Simpson J.L., Taslimi M., Najjar J., May S., Mills G., Crawford C., New M. First trimester prenatal treatment and molecular genetic diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency). [Review]. J. Clin. Endocrinol. Metab. 1990, 70: 838–848.
Forest M.G., David M., Morel Y. Prenatal diagnosis and treatment of 21-hydroxylase deficiency. J. Steroid Biochem. Mol. Biol. 1993, 45: 75–82.
Lahiri D., Nurnberger J. A rapid non-enzimatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic. Acids Res. 1991, 19: 5444.
Weddel A., Luthman H. Steroid 21-hydroxylase deficiency: two additional mutations in salt-wasting disease and rapid screening of disease-causing mutations. Hum. Mol. Genet. 1993, 2: 499–504.
Wedell A., Thilén A., Ritzén M., Stengler B., Luthman H. Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: Implications for genetic diagnosis and association with disease manifestation. J. Clin. Endocrinol. Metab. 1994, 78: 1145–1152.
Wilson R., Wei J.Q., Cheng K.C., Mercado M., New M. Rapid deoxyribonucleic acid analysis by allele-specific polymerase chain reaction for detection of mutations in the steroid 21-hydroxylase gene. J. Clin. Endocrinol. Metab. 1995, 80: 1635–1640.
Speiser P.W., Dupont J., Zhu D., Serrat J., Buegeleisen M., Tusie-Luna M.T., Lesser M., New M.I., White P.C. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Invest. 1992, 90: 584–595.
Carrera P., Bordone L., Azzani T., Brunelli V., Garancini M.P., Chiumello G., Ferrari M. Point mutations in Italian patients with classic, non-classic, and cryptic forms of steroid 21-hydroxylase deficiency. Hum. Genet. 1996, 98: 662–665.
Carrera P., Ferrari M., Beccaro F., Spiga I., Zanussi M., Rigon F., Braggion F., Zacchello F., Greggio N. Molecular characterization of 21-hydroxylase deficiency in 70 Italian families. Hum. Hered. 1993, 43: 190–196.
Barbat B., Bogyo A., Raux-Demay M.C., Kuttenn F., Boué J., Simon-Bouy B., Serre J.L., Boué A., Mornet E. Screening of CYP21 gene mutations in 129 French patients affected by steroid 21hydroxylase deficiency. Hum. Mutat. 1995, 5: 126–130.
Higashi Y., Hiromasa T., Tanae A., Miki T., Nakura Y., Kondo T., Ohura T., Ogawa E., Nakayama K., Fujii-Kuriyama Y. Effects of individual mutations in the P-450(c21) activity and their distribution in the patients genomes of congenital steroid 21-hydroxylase deficiency. J. Biochem. 1991, 109: 638–644.
Dardis A., Bergada I., Rivarola M., Belgorosky A. Mutations of the steroid 21-hydroxylase gene in an Argentinian population of 36 patients with classical congenital adrenal hyperplasia. J. Pediatr. Endocrinol. Metab. 1997, 10: 55–61.
Ordoñez-Sanchez M.L., Ramirez-Jimenez S., Lopez-Gutierrez A.U., Riba L., Gamboa-Cardiel S., Cerrillo-Hinojosa M., Altamirano-Bustamante N., Calzada-León R., Robles-Valdez C., Mendoza-Morfin F., Tusie-Luna T. Molecular genetic analysis of patients carring steroid 21-hydroxylase deficiency in the Mexican population: Identification of possible new mutations and high prevalence of apparent germ-line mutations. Hum. Genet. 1998, 102: 170–177.
Cruz-Coke R., Moreno R.S. Genetic epidemiology of single gene defects in Chile. J. Med. Genet. 1994, 31: 702–706.
Lisker R., Ramirez E., Briceno R.P., Granados J., Babinsky V. Gene frequencies and admixture estimates in four Mexican urban centers. Hum. Biol. 1990, 62: 791–801.
Tiburcio V., Romero A., De Garay A.L. Gene frequencies and racial intermixture in a mestizo population from Mexico City. Ann. Hum. Biol. 1978, 5: 131–138.
Wallace D.C., Torroni A. American indian prehistory as written in the mitochondrial DNA: a review. Hum. Biol. 1992, 64: 403–416.
Tusié-Luna M.T., Ramírez-Jiménez S., Ordóñez-Sánchez M.L., Cabello-Villegas J., Altamirano-Bustamante N., Calzada-León R., Robles-Valdés C., Mendoza-Morfín F., Méndez J.P., Terán-García ??. Low frequency of deletion alleles in patients with steroid 21-hydroxylase deficiency in a Mexican population. Hum. Genet. 1996, 98: 376–379.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fardella, C.E., Poggi, H., Soto, J. et al. Mutations in the CYP21B gene in a Chilean population with simple virilizing congenital adrenal hyperplasia. J Endocrinol Invest 23, 412–416 (2000). https://doi.org/10.1007/BF03343746
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03343746